Shanghai Yizhong Pharmaceutical Co Ltd (688091) — Financial Flexibility Index
Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Financial Flexibility Index of 0.62x as of September 2025. Free cash flow of CN¥51.39 Million (operating CF CN¥21.03 Million minus capex CN¥30.36 Million) represents 1% of total liabilities (CN¥82.76 Million). Check Shanghai Yizhong Pharmaceutical Co Ltd (688091) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shanghai Yizhong Pharmaceutical Co Ltd Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Shanghai Yizhong Pharmaceutical Co Ltd across 8 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Shanghai Yizhong Pharmaceutical Co Ltd.
Annual Financial Flexibility Index for Shanghai Yizhong Pharmaceutical Co Ltd (2017–2024)
Year-by-year free cash flow to debt coverage for Shanghai Yizhong Pharmaceutical Co Ltd. Explore debt repayment capacity of Shanghai Yizhong Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.78x | CN¥119.47 Million | CN¥39.44 Million | CN¥42.97 Million | ▲ +216.5% |
| 2023 | 0.88x | CN¥95.34 Million | CN¥86.55 Million | CN¥108.52 Million | ▼ -78.8% |
| 2022 | 4.14x | CN¥146.67 Million | CN¥110.78 Million | CN¥35.42 Million | ▲ +327.0% |
| 2021 | -1.82x | CN¥-45.64 Million | CN¥-48.78 Million | CN¥25.02 Million | ▼ -83.6% |
| 2020 | -0.99x | CN¥-15.21 Million | CN¥-20.21 Million | CN¥15.30 Million | ▼ -151.5% |
| 2019 | 1.93x | CN¥23.67 Million | CN¥-23.91 Million | CN¥12.26 Million | ▲ +558.4% |
| 2018 | -0.42x | CN¥-7.22 Million | CN¥-10.68 Million | CN¥17.15 Million | ▲ +34.4% |
| 2017 | -0.64x | CN¥-10.38 Million | CN¥-11.51 Million | CN¥16.17 Million | — |